Medical research

Researchers pinpoint keys to cell therapy response for leukemia

Dana-Farber Cancer Institute researchers have identified factors that determine whether donor lymphocyte infusion (DLI), a standard therapy for patients with acute myeloid leukemia (AML) who have relapsed after allogenic ...

page 2 from 40